Ayrloom Nearly Doubles Annual Sales in New York Cannabis Market

Revenue Growth Tied to Retail Expansion

Ayrloom's sales surge reflects New York's accelerating dispensary count, which has grown from fewer than 50 licensed adult-use stores in early 2024 to more than 200 by mid-2026. The brand operates across multiple retail channels in the state, benefiting from the OCM's push to license legacy operators and conditional cultivators.

The cleanest read on Ayrloom's growth is distribution scale. More doors open, more revenue flows. The company hasn't disclosed unit economics or margin data.

New York Market Still Competing with Illicit Sales

New York's legal market captured an estimated 35% of total cannabis sales in 2025, according to state tax filings, leaving $2.3 billion in annual illicit revenue on the table. Ayrloom's growth trajectory depends on the OCM's ability to close that gap through enforcement and price compression.

The brand's 94% growth rate outpaces the statewide legal market expansion, which grew 68% year-over-year in the same period, suggesting Ayrloom is winning shelf space at competitors' expense.

For full background on New York's retail rollout and enforcement challenges, see the CannIntel topic hub on the New York cannabis market.

What to Watch

The next test for Ayrloom and other New York brands is margin sustainability as wholesale prices compress. Flower wholesale prices in New York dropped 22% in the first half of 2026, according to state transaction data. Brands that scaled on volume alone will face profitability pressure if retail pricing follows wholesale down.

By year-end 2026, the OCM is expected to issue 100 additional adult-use licenses. Whether Ayrloom can sustain 90%-plus growth into 2027 depends on whether those new stores cannibalize existing accounts or expand the addressable market.